These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
136 related items for PubMed ID: 11093785
41. Allosteric interactions at muscarinic cholinoceptors. Christopoulos A, Lanzafame A, Mitchelson F. Clin Exp Pharmacol Physiol; 1998; 25(3-4):185-94. PubMed ID: 9590567 [Abstract] [Full Text] [Related]
42. Binding of N-methylscopolamine to the extracellular domain of muscarinic acetylcholine receptors. Jakubík J, Randáková A, Zimčík P, El-Fakahany EE, Doležal V. Sci Rep; 2017 Jan 16; 7():40381. PubMed ID: 28091608 [Abstract] [Full Text] [Related]
43. Determinants of positive cooperativity between strychnine-like allosteric modulators and N-methylscopolamine at muscarinic receptors. Jakubík J, Dolezal V. J Mol Neurosci; 2006 Jan 16; 30(1-2):111-2. PubMed ID: 17192652 [Abstract] [Full Text] [Related]
44. Role of acidic amino acids in the allosteric modulation by gallamine of antagonist binding at the m2 muscarinic acetylcholine receptor. Leppik RA, Miller RC, Eck M, Paquet JL. Mol Pharmacol; 1994 May 16; 45(5):983-90. PubMed ID: 8190113 [Abstract] [Full Text] [Related]
45. Allosteric modulation by persistent binding of xanomeline of the interaction of competitive ligands with the M1 muscarinic acetylcholine receptor. Jakubík J, Tucek S, El-Fakahany EE. J Pharmacol Exp Ther; 2002 Jun 16; 301(3):1033-41. PubMed ID: 12023535 [Abstract] [Full Text] [Related]
48. Positive and negative allosteric interactions on muscarinic receptors. Hejnová L, Tucek S, el-Fakahany EE. Eur J Pharmacol; 1995 Nov 30; 291(3):427-30. PubMed ID: 8719429 [Abstract] [Full Text] [Related]
49. The impact of orthosteric radioligand depletion on the quantification of allosteric modulator interactions. Avlani VA, McLoughlin DJ, Sexton PM, Christopoulos A. J Pharmacol Exp Ther; 2008 Jun 30; 325(3):927-34. PubMed ID: 18322151 [Abstract] [Full Text] [Related]
56. Two populations of muscarinic binding sites in the chick heart distinguished by affinities for ligands and selective inactivation. Jakubík J, Tucek S. Br J Pharmacol; 1994 Dec 28; 113(4):1529-37. PubMed ID: 7889311 [Abstract] [Full Text] [Related]
58. Allosteric site in M2 acetylcholine receptors: evidence for a major conformational change upon binding of an orthosteric agonist instead of an antagonist. Grossmüller M, Antony J, Tränkle C, Holzgrabe U, Mohr K. Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan 28; 372(4):267-76. PubMed ID: 16362429 [Abstract] [Full Text] [Related]
59. Site-directed mutagenesis implicates a threonine residue in TM6 in the subtype selectivities of UH-AH 37 and pirenzepine at muscarinic receptors. Ellis J, Seidenberg M. Pharmacology; 2000 Aug 28; 61(2):62-9. PubMed ID: 10940778 [Abstract] [Full Text] [Related]